Stating the obvious, but the post recent roadshow presentation is a good place to start, and there's a link to a research report on the company home page. On the one hand you always have to be careful with research reports (if every research report were true half the stocks on the ASX would have ten bagged by now). On the other hand, the valuations do represent a reasonable best case scenario (that's the van Leewunhoeck or whatever it is report from Nov 17)
The fully diluted share register is about 200m so I calculate a "worst case market cap" (worst case because it implies less upside) by doubling the share price. I happen to think a 40c price or $80m market cap for a company with growing sales and income for a current product and decent Phase II results in a market space worth >> $10b is undervalued.
Add to My Watchlist
What is My Watchlist?
